Skip to main content
. 2021 Jan 13;3(5):609–618. doi: 10.1016/j.cjco.2021.01.003

Table 2.

One-year crude outcome incidence according to fiscal year

Variable 2006 2007 2008 2009 2010 2011 2012 2013 2014 Total P
Patient n 53,544 50,494 50,178 50,033 50,505 51,998 52,803 53,066 53,855 466,476
Stroke/embolism, n (%) 1917 (3.6) 1737 (3.4) 1761 (3.5) 1728 (3.5) 1904 (3.8) 1843 (3.5) 1822 (3.5) 1790 (3.4) 1760 (3.3) 16,262 (3.5) 0.002
Ischemic stroke, n (%) 1498 (2.8) 1341 (2.7) 1357 (2.7) 1329 (2.7) 1468 (2.9) 1403 (2.7) 1405 (2.7) 1389 (2.6) 1359 (2.5) 12,549 (2.7) 0.016
Hemorrhagic stroke, n (%) 352 (0.7) 311 (0.6) 359 (0.7) 320 (0.6) 357 (0.7) 358 (0.7) 335 (0.6) 341 (0.6) 329 (0.6) 3062 (0.7) 0.32
Major bleeding, n (%) 923 (1.7) 798 (1.6) 880 (1.8) 774 (1.5) 820 (1.6) 845 (1.6) 856 (1.6) 900 (1.7) 865 (1.6) 7661 (1.6) 0.16
Patient n 39,069 37,180 36,918 37,252 37,886 39,297 39,973 39,887 40,185 347,647
New HF, n (%) 3547 (9.1) 3235 (8.7) 3221 (8.7) 3106 (8.3) 3214 (8.5) 3326 (8.5) 3388 (8.5) 3433 (8.6) 3459 (8.6) 29,929 (8.6) 0.021

AF, atrial fibrillation; HF, heart failure.

P value from Cochrane Armitage trend test.

Excluding patients with previous 2-year history of HF/HF during the index AF episode.